Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

 507.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 913.00
  • 52 Week Low: 478.50
  • Currency: UK Pounds
  • Shares Issued: 121.04m
  • Volume: 0
  • Market Cap: £613.70m
  • RiskGrade: 125
  • Beta: 0.03

Latest ShareCast News

Deutsche Bank downgrades Oxford Biomedica after 'disappointing' H1 results

By Michele Maatouk

Date: Tuesday 18 Aug 2026

(Sharecast News) - Deutsche Bank downgraded Oxford Biomedica to 'hold' from 'buy' on Tuesday and slashed the price target to 595p from 800p as it revisited the investment case following the "disappointing" first-half trading update.

OXB Regulatory News

Total Voting Rights 02-Jan-2026 07:00 RNS
Block Listing Return 02-Jan-2026 07:00 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 507.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 913.00
52 Week Low 478.50
Volume 0
Shares Issued 121.04m
Market Cap £613.70m
Beta 0.03
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

OXB Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page